BAC vs LLY: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Eli Lilly and Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Bank of America Corporation · Financial Services
$57.96
+15.7% upside to fair value
Med Conviction
Grade B
VS
Eli Lilly and Company · Healthcare
$1,183.72
+2.1% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
BAC has more upside to fair value
(+15.7%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
LLY |
| Current Price |
$57.96 |
$1,183.72 |
| Fair Value Estimate |
$67.08 |
$1,208.00 |
| Upside to Fair Value |
+15.7%
|
+2.1%
|
| Market Cap |
$411.3B |
$1,114.8B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.4x
|
26.8x
|
| Price / Sales |
2.1x
|
14.0x
|
| Price / FCF |
4.4x
|
52.7x
|
| Revenue Growth YoY |
+5.8%
|
+47.7%
|
| Gross Margin |
59.3%
|
83.4%
|
| Operating Margin |
22.5%
|
49.7%
|
| Return on Equity |
11.1%
|
92.6%
|
| Dividend Yield |
2.0% |
0.57% |
| FCF Yield |
22.88%
|
1.9%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Bank of America Corporation is a diversified U.S. money-center bank operating through Consumer Banking, Global Wealth & Investment Management, Global Banking, and Global Markets, serving roughly 67 million consumer and small business clients through about 4,200 retail financial centers and 16,000 ATMs as of the last detailed disclosure. The franchise quality is solid but not exceptional: TTM net …
Eli Lilly is a global pharmaceutical company whose incretin franchise, led by Mounjaro and Zepbound, has become the dominant growth engine in diabetes and obesity care. The business quality is high: TTM gross margin is 83.4%, TTM operating margin is 49.7%, TTM net margin is 33.5%, and ROE is 92.6%, while revenue grew 47.7% and earnings grew 25.3% in the most recent quarter on a year-over-year bas…
Accumulation Zones
| Metric |
BAC |
LLY |
| Zone Low |
$50.31 |
$906.00 |
| Zone High |
$57.02 |
$1,026.80 |
| In Buy Zone? |
No
|
No
|